Skip to main content
SpringerLink
Log in

Proteases and Prion Diseases

  • Chapter
Proteases In The Brain

Part of the book series: Proteases In Biology and Disease ((PBAD,volume 3))

  • 380 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  • Adair JC, Charlie J, Dencoff JE, Kaye JA, Quinn JF, Camicioli RM, Stetler-Stevenson WG, Rosenberg GA, 2004, Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with Vascular Dementia and Alzheimer disease. Stroke 35:E152–E162.

    Article  Google Scholar 

  • Aguzzi A, 2004, Understanding the diversity of prions.Nat Cell Biol. 6:290–292.

    Article  CAS  PubMed  Google Scholar 

  • Béranger F, Mangé A, Goud B, Lehmann S, 2002,Stimulation of PrPC retrograde transport toward the endoplasmic reticulum increases accumulation of PrPSc in prion-infected cells. J Biol Chem. 277:38972–38977.

    PubMed  Google Scholar 

  • Bernstein H-G, Keilhoff G, Bukowska A, Ziegeler A, Funke S, Dobrowolny H, Kanakis D, Bogerts B, Lendeckel U, 2004,ADAM (A disintegrin and metalloprotease) 12 is expressed in rat and human brain and localized to oligodendrocytes.J Neurosci Res. 75:353–360.

    Article  CAS  PubMed  Google Scholar 

  • Blobel CP, 2000, Remarkable roles of proteolysis on and beyond the cell surface. Curr Opin Cell Biol. 12:606–612.

    Article  CAS  PubMed  Google Scholar 

  • Brown DR, Clive C, Haswell SJ, 2001, Antioxidant activity related to copper binding of native prion protein. J Neurochem. 76:69–76.

    Article  CAS  PubMed  Google Scholar 

  • Brown DR, 2001, Prion and prejudice: normal protein and the synapse. Trends Neurosci 24:85–90

    CAS  PubMed  Google Scholar 

  • Brown DR, 2002, Copper and prion diseases. Biochem Soc Trans. 30:742–745.

    CAS  PubMed  Google Scholar 

  • Brown DR, 2003. Prion protein expression modulates neuronal copper content. J Neurochem. 87:377–385.

    CAS  PubMed  Google Scholar 

  • Capellari S, Parchi P, Russo CM, Sanford J, Sy MS, Gambetti P, Petersen RB, 2000, Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. Am J Pathol. 157:613–622.

    CAS  PubMed  Google Scholar 

  • Cartier L, García L, Kettlun AM, Castañeda P, Collados L, Vásquez F, Giraudon P, Belin MF, Valenzuela MA, 2003, Extracellular matrix protein expression in cerebrospinal fluid from patients with tropical spastic paraparesis associated with HTLV-I and Creutzfeldt-Jakob disease. Scand J Clin Lab Invest. 64:101–107.

    Google Scholar 

  • Caughey B, 2003, Prion protein conversions: insight into mechanism, TSE transmission barriers and strains. Br Med Bull.66:109–120

    CAS  PubMed  Google Scholar 

  • Cereghetti GM, Schweiger A, Glockshuber R, van Doorslaer S, 2003, Stability and Cu(II) binding of prion protein variants related to inherited human prion diseases. Biophys J. 84:1985–1997

    CAS  PubMed  Google Scholar 

  • Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L, 1995, Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem. 270:19173–19180.

    CAS  PubMed  Google Scholar 

  • Choi YG, Kim JI, Jeon YC, Park SJ, Choi EK, Rubenstein R, Kascsak RJ, Carp RJ, Kim YS, 2004, Nonenzymatic glycation at the N-terminus of pathogenic prion protein in transmissible spongiform encephalopathies. J Biol Chem.279:30402–30409.

    CAS  PubMed  Google Scholar 

  • Collinge J, 2001, Prion diseases of human and animals: their causes and molecular basis. Annu Rev Neurosci. 24: 519–550.

    Article  CAS  PubMed  Google Scholar 

  • Corsaro A, Thellung S, Villa V, Principe DR, Paludi D, Arena S, Millo E, Schettini D, Damonte G, Aceto A, Schettini G, Florio T, 2003, Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation. Ann N Y Acad Sci. 1010:610–622.

    Article  CAS  PubMed  Google Scholar 

  • Crocker SJ, Pagenstecher A, Campbell IL, 2004, The TIMPs tango with MMPs and more in the central nervous system. J Neurosci Res. 75:1–11.

    Article  CAS  PubMed  Google Scholar 

  • Cui T, Daniels M, Wong BS, Li R, Sy MS, Sassoon J, Brown DR, 2003, Mapping the functional domain of the prion protein. Eur J Biochem. 270:3368–3374.

    Article  CAS  PubMed  Google Scholar 

  • Demaerel P, Sciot R, Robberecht W, Dora R, Vandermeulen D, Maes F, Wilms G, 2003, Accuracy of diffusion-weighted MR imaging in the diagnosis of sporadic Creutzfeldt-Jakob disease. J Neural. 250:222–225.

    Google Scholar 

  • Drisaldi B, Stewart RS, Adles C, Stewart LR, Quaglio E, Biasini E, Fioriti L, Chiesa R, Harris DA, 2003, Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Ghent. 278:21732–21743.

    CAS  Google Scholar 

  • Ermonval M, Mouillet-Richard S, Codogno P, Kellermann O, Botti J, 2003, Evolving views in prion glycosylation: functional and pathological implications. Biochimie. 85:33–45.

    Article  CAS  PubMed  Google Scholar 

  • Ellis V, Daniels M, Misra R, Brown DR, 2002, Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner. Biochemistry 41:6891–6896.

    Article  CAS  PubMed  Google Scholar 

  • Gardner J, Ghorpade A, 2003, Tissue inhibitor of metalloproteinase (TIMP)-l: the TIMPed balance of matrix metalloproteinases in the central nervous system. J Neurosci Res. 74:801–806.

    Article  CAS  PubMed  Google Scholar 

  • Garnett AP, Viles JH, 2003, Copper binding to the octarepeats of the prion protein. Affinity, specificity, folding, and cooperativity: insights from circular dichroism. J Biol Chem. 278:6795–6802.

    Article  CAS  PubMed  Google Scholar 

  • Goldfarb LG, Brown P, Mitrová E, Cervenáková L, Goldin L, Korcyn AD, Chapman J, Gálvez S, Rubenstein R, Gajdusek DC, 1991, Creutzfeldt-Jakob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families.Eur J Epidemiol. 7:477–486.

    Article  CAS  PubMed  Google Scholar 

  • Green AJ, 2002, Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer’s disease and Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol. 28:427–440.

    Article  CAS  PubMed  Google Scholar 

  • Hachiya NS, Watanabe K, Yamada M, Sakasegawa Y, Kaneko K, 2004, Anterograde and retrograde intracellular trafficking of fluorescent cellular prion protein. Biochem Biophys Res Commun. 315:802–807

    Article  CAS  PubMed  Google Scholar 

  • Harris DA, 1999, Cellular biology of prion diseases. Clin Microbiol Rev. 12:429–444.

    CAS  PubMed  Google Scholar 

  • Harris DA, 2003, Trafficking, turnover and membrane topology of PrP. Br Med Bull. 66:71–85.

    CAS  PubMed  Google Scholar 

  • Heske J, Heller U, Winklhofer KF, Tatzelt J, 2004, The C-terminal globular domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum. J Biol Chem. 279:5435–5443.

    CAS  PubMed  Google Scholar 

  • Hetz C, Soto C, 2003, Protein misfolding and disease: the case of prion disorders. Cell Mol Life Sci. 60:133–43.

    CAS  PubMed  Google Scholar 

  • Hetz C, Russelakis-Carneiro M, Maundell K, Castilla J, Soto C, 2003, Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22:5435–5445

    Article  CAS  PubMed  Google Scholar 

  • Hijazi N, Shaked Y, Rosenmann H, Ben-Hur T, Gabizon R, 2003, Cooper binding to PrPC may inhibit prion disease propagation. Brain Res. 993:192–200.

    Article  CAS  PubMed  Google Scholar 

  • Hooper NM, 2003, Could inhibition of the proteasome cause mad cow disease? Trends Biotechnol. 21:144–145.

    Article  CAS  PubMed  Google Scholar 

  • Huang Y, Wang KK, 2001, The calpain family and human disease. Trends Mol Med. 7:355–362.

    Article  CAS  PubMed  Google Scholar 

  • Ivanova L, Barmada S, Kummer T, Harris DA, 2001, Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem. 276:42409–42421.

    CAS  PubMed  Google Scholar 

  • Jarius C, Kovács GG, Belay G, Hainfellner JA, Mitrova E, Budka H, 2003, Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease. Acta Neuropathol. 105:449–454.

    CAS  PubMed  Google Scholar 

  • Jiménez-Huete A, Lievens JPM, Vidal R, Piccardo P, Ghetti B, Tagliavini F, Frangione B, Prelli F, 1998, Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am J Pathol. 153:1561–1572.

    PubMed  Google Scholar 

  • Johnson RT, Gibbs CJ Jr, 1998, Creutzfeldt-Jakon disease and related transmissible spongiform encephalopathies. N Engl J Med. 339:1994–2004.

    CAS  PubMed  Google Scholar 

  • Kang SC, Brown DR, Whiteman M, Li R, Pan T, Perry G, Wisniewski T, Sy MS, Wong BS, 2004, Prion protein is ubiquitinated after developing protease resistance in the brains of scrapied-infected mice. J Pathol. 203:603–608.

    Article  CAS  PubMed  Google Scholar 

  • Kapaki E, Kilidireas K, Paraskevas GP, Michalopoulou M, Patsouris E, 2001, Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimerar’s disease? J Neural Neurosurg Psychiatry 71:401–403.

    CAS  Google Scholar 

  • Kärkkäinen I, Rybnikova E, Pelto-Huikko M, Huovila AP, 2000, Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol Cell Neurosci. 15:547–560.

    PubMed  Google Scholar 

  • Kettlun A, Collados L, Garcia L, Cartier LA, Wolf ME, Mosnaim AD, Valenzuela MA, 2003a, Matrix metalloproteinase profile in patients with Creuztfeldt-Jakob disease. Int J Clin Pract. 57:475–478.

    CAS  PubMed  Google Scholar 

  • Kettlun AM, Cartier L, Garcia L, Collados L, Vásquez F, Ramírez E, Valenzuela MA, 2003b, TIMPs and MMPs expression in CSF from patients with TSP/HAM. Life Sci. 72:2863–2876.

    Article  CAS  PubMed  Google Scholar 

  • Kim BH, Lee HG, Choi JK, Kim JI, Choi EK, Carp RI, Kim YS, 2004, The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation. Brain Res Mol Brain Res. 124:40–50.

    CAS  PubMed  Google Scholar 

  • Kovács GG, Head MW, Bunn T, Laszlo L, Will RG, Ironside JW,2000, Clinicopathological phenotype of codon 129 valine homozygote sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol. 26:463–472.

    PubMed  Google Scholar 

  • Kovács GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H, 2002, Mutations of the prion protein gene. J Neurol. 249:1567–1582.

    PubMed  Google Scholar 

  • Lasmézas CI, 2003, Putative function of PrPC. Br Med Bull. 66:61–70.

    PubMed  Google Scholar 

  • Lawson VA, Priola SA, Meade-White K, Lawson M, Chesebro B, 2004, Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro. J Biol Chem. 279:13689–13695.

    Article  CAS  PubMed  Google Scholar 

  • Li R, Liu T, Yoshihiro F, Tary-Lehmann M, Obrenovich M, Kuekrek H, Kang SC, Pan T, Wong BS, Medof ME, Sy MS. 2003, On the same cell type GPI-anchored normal cellular prion and DAF protein exhibit different biological properties. Biochem Biophys Res Commun. 303:446–451.

    Article  CAS  PubMed  Google Scholar 

  • Liu T, Li R, Pan T, Liu D, Petersen RB, Wong BS, Gambetti P, Sy MS, 2002, Intracellular transfer of the cellular prion protein. J Biol Chem. 277:47671–47678.

    CAS  PubMed  Google Scholar 

  • Ma J, Lindquist S, 2002, Conversion of PrP a self-perpetuating PrPSc-like conformation in the cytosol. Science 298:1785–1788.

    CAS  PubMed  Google Scholar 

  • Manaka H, Kato T, Kurita K, Katagiri T, Shikama Y, Kujirai K, Kawanami T, Suzuki Y, Nihei K, Sasaki H, Yamada S, Hirota K, Kusaka H, Imai T, 1992, Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob disease. Neurosci Lett. 139:47–49.

    Article  CAS  PubMed  Google Scholar 

  • Marella M, Lehmann S, Grassi J, Chabry J, 2002, Filipin prevents pathological prion protein accumulation by reducing endocytosis and inducing cellular PrP release. J Biol Chem. 277:25457–25464.

    Article  CAS  PubMed  Google Scholar 

  • Marella M, Chavry J, 2004, Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J Neurosci. 24:620–627.

    Article  CAS  PubMed  Google Scholar 

  • Martins VR, Linden R, Prado MA, Waltz R, Sakamoto AC, Izquierdo I, Brentani RR, 2002, Cellular prion protein: on the road for functions. FEBS Lett. 512:25–28.

    Article  CAS  PubMed  Google Scholar 

  • McMahon HE, Mangé A, Nishida N, Crémion C, Casanova D, Lehmann S, 2001, Cleavage of the amino terminus of the prion protein by reactive oxygen species.J Biol Chem. 276:2286–2291.

    CAS  PubMed  Google Scholar 

  • Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T, Uphill JB, Goldstein D, Alpers M, Fisher EM, Collinge J, 2003. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300:640–643.

    Article  CAS  PubMed  Google Scholar 

  • Millhauser GL, 2004, Copper binding in the prion protein.Acc Chem Res. 37:79–85

    Article  CAS  PubMed  Google Scholar 

  • Morford LA, Forrest K, Logan B, Overstreet LK, Goebel J, Brooks WH, Roszman TL, 2002, Calpain II colocalizes with detergent-insoluble rafts on human and Jurkat T-cells. Biochem Biophys Res Commun. 295:540–546.

    Article  CAS  PubMed  Google Scholar 

  • Nagase H, Woessner JF Jr, 1999, Matrix metalloproteinases. J Biol Chem. 274:21491–21494.

    Article  CAS  PubMed  Google Scholar 

  • Nishina K, Deleault NR, Lucassen RW, Supattapone S, 2004, In vitro prion protein conversion in detergent-solubilized membranes. Biochemistry 43:2613–2621.

    Article  CAS  PubMed  Google Scholar 

  • Notari S, Capellari S, Gieses A, Westner I, Baruzzi A, Ghetti B, Gambetti P, Kretzschmar HA, Parchi P, 2004, Effects of different experimental conditions on the PrPSc core generated by protease digestion. J Biol Chem. 279:16797–16804.

    Article  CAS  PubMed  Google Scholar 

  • Novak U, 2004, ADAM protein in the brain. J Clin Neurosci. 11:227–235

    Article  CAS  PubMed  Google Scholar 

  • O’Donovan CN, Tobin D, Cotter TG., 2001, Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells. J Biol Chem. 276:43516–43523.

    CAS  PubMed  Google Scholar 

  • Pan T, Colucci M, Wong BS, Li R, Liu T, Petersen RB, Chen S, Gambetti P, Sy MS, 2001, Novel differences between two human prion strains revealed by two dimensional gel electrophoresis. J Biol Chem. 276:37284–37288.

    CAS  PubMed  Google Scholar 

  • Pan T, Wong BS, Liu T, Li R, Petersen RB, Sy MS, 2002, Cell-surface prion protein interacts with glycosaminoglycans. Biochem J. 368:81–90.

    Article  CAS  PubMed  Google Scholar 

  • Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H, 1999, Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.Ann Neurol. 46:224–233.

    Article  CAS  PubMed  Google Scholar 

  • Parchi P, Zou W, Wang W, Brown P, Capellari S, Ghetti B, Kopp N, Schultz-Schaeffer WJ, Kretzschmar HA, Head MW, Ironside JW, Gambetti P, Chen SC, 2000, Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 97:10168–10172

    Article  CAS  PubMed  Google Scholar 

  • Parizek P, Roeckl C, Weber J, Flechsig E, Aguzzi A, Raeber AJ, 2001, Similar turnover and shedding of the cellular prion protein in primary lymphoid and neuronal cells. J Biol Chem. 276:44627–44632.

    Article  CAS  PubMed  Google Scholar 

  • Parkin ET, Watt NT, Turner AJ, Hooper NM, 2004,Dual mechanisms for shedding of the cellular prion protein. J Biol Chem. 279:11170–11178.

    Article  CAS  PubMed  Google Scholar 

  • Plamont M-A, Chasseigneaux S, Delasnerie-Lauprêtre N, Beaudry P, Peoc’h K, Laplanche JL, 2003, Variation at the ADAM10 gene locus is not associated with Creutzfeldt-Jakob disease. Neurosci Lett. 344:132–134.

    Article  CAS  PubMed  Google Scholar 

  • Prado MA, Alves-Silva J, Magalhaes AC, Prado VF, Linden R, Martins VR, Brentani RR, 2004, PrPc on the road: trafficking of the cellular prion protein. J Neurochem. 88:769–781.

    CAS  PubMed  Google Scholar 

  • Primakoff P, Myles DG, 2000, The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 16:83–87.

    Article  CAS  PubMed  Google Scholar 

  • Prusiner SB, 1998, Prions. Proc Natl Acad Sci USA, 95:13363–13383

    Article  CAS  PubMed  Google Scholar 

  • Rachidi W, Vilette D, Guiraud P, Arlotto M, Riondel J, Laude H, Lehmann S, Favier A, 2003, Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem. 278:9064–9072.

    CAS  PubMed  Google Scholar 

  • Rosenberg GA, 2002, Matrix metalloproteinases in neuroinflammation, Glia 39:279–291.

    Article  PubMed  Google Scholar 

  • Rossi L, Lombardo MF, Ciricelo MR, Rotilio G, 2004, Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem Res. 29:493–504.

    Article  CAS  PubMed  Google Scholar 

  • Roucou X, Guo Q, Zhang Y, Goodyer CG, LeBlanc AC, 2003, Cytosolic prion protein is not toxic and protects against bax-mediated cell death in human primary neurons. J Biol Chem. 278: 40877–40881.

    Article  CAS  PubMed  Google Scholar 

  • Sisó S, Puig B, Varea R, Vidal E, Acín C, Prinz M, Monstrasio F, Badiola J, Aguzzi A, Pumarola M, Ferrer I, 2002, Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol. 103:615–626.

    PubMed  Google Scholar 

  • Sternlicht MD, Werb Z, 2001, How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 17:463–516.

    Article  CAS  PubMed  Google Scholar 

  • Tenzer S, Stoltze L, Schonfisch B, Dengjel J, Muller M, Stevanovic S, Rammensee HG, Schild H, 2004, Quantitative analysis of prion-protein degradation by constitutive and immuno-20S proteasomes indicates differences correlated with disease susceptibility. J Immunol. 172:1083–91.

    CAS  PubMed  Google Scholar 

  • Thackray AM, Knight R, Haswell SJ, Bujdoso R, Brown DR, 2002, Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem J. 362:253–258.

    Article  CAS  PubMed  Google Scholar 

  • Turnbull S, Tabner BJ, Brown DR, Allsop D, 2003, Copper-dependent generation of hydrogen peroxide from the toxic prion protein fragment PrP106-126.Neurosci Lett. 336:159–162

    Article  CAS  PubMed  Google Scholar 

  • Valenzuela MA, Cartier L, Collados L, Kettlun AM, Araya F, Concha C, Flores L, Wolf ME, Mosnaim AD, 1999, Gelatinase activity of matrix metalloproteinases in the cerebrospinal fluid of various patient populations. Res Commun Mol Pathol Pharmacol. 104:42–52.

    CAS  PubMed  Google Scholar 

  • Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G, 2002, Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 37:375–536.

    PubMed  Google Scholar 

  • VanSaum M, Werle MJ, 2000, Matrix metalloproteinase-3 removes agrin from synaptic basal lamina. J Neurobiol. 43:140–149.

    Google Scholar 

  • Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J, Lopez-Perez E, Checler F, 2001, The disintegrins ADAM 10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem. 276:37743–37746.

    Article  CAS  PubMed  Google Scholar 

  • Visse R, Nagase H, 2003, Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 92:827–839.

    Article  CAS  PubMed  Google Scholar 

  • Will RG,, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hoffman A, Smith PG, 1996, A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921–925.

    Article  CAS  PubMed  Google Scholar 

  • Wong BS, Pan T, Liu T, Li R, Petersen RB, Jones IM, Gambetti P, Brown DR, Sy MS, 2000, Prion disease a loss of antioxidant function? Biochem Biophys Res Commun. 275:249–52.

    Article  CAS  PubMed  Google Scholar 

  • Wong E, Thackray AM, Budjoso R, 2004, Copper induced increased beta-sheet content in the scrapie susceptible ovine prion protein PrPVRQ compared to the resistant allelic variant PrPARR. Biochem J. 380:273–282.

    Article  CAS  PubMed  Google Scholar 

  • Yadavalli R, Guttmann RP, Seward T, Centers AP, Williamson RA, Telling GC, 2004, Calpain-dependent endoproteolytic cleavage of PrP modulates scrapie prion propagation. J Biol Chem. 279:21948–21956.

    Article  CAS  PubMed  Google Scholar 

  • Yedidia Y, Horonchik L, Tzaban S, Yanai A, Taraboulos A, 2001, Proteasomes and ubiquitin are envolved in the turnover of the wild-type prion protein. EMBO J. 20:5383–5391.

    Article  CAS  PubMed  Google Scholar 

  • Yong VW, Power C, Forsyth P, Edwards DR, 2001, Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci. 2:502–511.

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y, Spiess E, Groschup MH, Burkle A, 2003, Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells. J Gen Virol. 84: 2279–2283.

    CAS  PubMed  Google Scholar 

  • Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, 2003, Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob Disease. J Biol Chem. 278:40429–40436.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile

    M. Antonieta Valenzuela, Ana María Kettlun, Lucía Collados & Lorena Garcia

  2. Departamento de Ciencias Neurológicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile

    Luis Cartier

  3. Rosalind Franklin University/The Chicago Medical School, N. Chicago, IL, USA

    Aron D. Mosnaim

  4. International Neuropsychiatry Consultants, Highland Park, IL., USA

    Marion E. Wolf

Authors
  1. M. Antonieta Valenzuela
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luis Cartier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aron D. Mosnaim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marion E. Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana María Kettlun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lucía Collados
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lorena Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Otto-von-Guericke University, Magdeburg, Germany

    Uwe Lendeckel

  2. University of Leeds, Leeds, UK

    Nigel M. Hooper

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science + Business Media, Inc. Dordrecht

About this chapter

Cite this chapter

Valenzuela, M.A. et al. (2005). Proteases and Prion Diseases. In: Lendeckel, U., Hooper, N.M. (eds) Proteases In The Brain. Proteases In Biology and Disease, vol 3. Springer, Boston, MA. https://doi.org/10.1007/0-387-23101-3_8

Download citation

Publish with us

Policies and ethics

Search

Navigation